title: [Prevention of renal carcinoma: the nutri-genetic approach].
abstract: The development of renal cell carcinoma (RCC) has been associated with both genetic and environmental factors, with somatic and germline mutations in the von Hippel-Lindau (VHL) tumor suppressor gene and with tobacco smoking, obesity, long term exposure to some nutrients, pollutants, and industrial solvents such as trichloroethylene. Intra and interfamilial variability of expression of germline mutations in the VHL gene and variable susceptibility to carcinogens in the sporadic forms strongly suggest the involvement of conditional modifier genes. In order to identify sub groups of individuals at increased risk because of susceptibility genotypes, we have collected a series of 460 patients who developed an RCC and 79 families with the von Hippel Lindau disease. To collect clinical and mutational data for correlation analysis we have developed a unique tool the Universal Mutation Database. Comparison of the spectrum of germline and somatic mutations in the VHL gene showed that: 1) in sporadic RCC mutations lead more often to truncated proteins (83%), while the remaining mutations (17%), include 3/4 of transversions and 1/4 of transitions. This high proportion of transversions supports the involvement of carcinogens the impact of which is conditioned by the genetic variability of xenobiotic metabolizing enzymes; 2) whereas in familial cases missense mutations are more common; this difference allowed us to define a prognostic factor for the occurrence of RCC in a VHL context. In order to look for genotypes conferring a higher risk we genotyped the RCC patients for 8 different genes (50 genotypes). A significant relationship was observed for several combinations of alleles including CYP1A1 ("variant"), NAT2 and NAT1 (slow) and GSTM1 (null allele). Associations between specific mutational profiles and at risk genotypes at different tumoral stages should allow us to: 1) define more precisely the nature of specific patterns of mutations in relation with the deficiency or overexpression of such or such enzymes in presence of particular carcinogens; 2) demonstrate that certain combinations of genotypes confer a particular risk to develop a specific type of tumor in VHL patients. Thus tracking of potentially carcinogenic substances, through their footprints and through identification of conditionally detrimental genotypes of genes participating in their detoxification should permit a better prevention through an appropriate nutrition adapted to each individual.
authors: Inserm Unité de Recherche 383 Génétique, Chromosome et Cancer, Groupe Hospitalier Necker Enfants Malades, Paris.
authors: C
authors: C
authors: Junien
authors: J M
authors: JM
authors: Dupret
authors: C
authors: C
authors: Gallou
authors: S
authors: S
authors: Longuemaux
authors: S
authors: S
authors: Richard
authors: C
authors: C
authors: Saquet
authors: R
authors: R
authors: Krishnamoorty
authors: C
authors: C
authors: Delomenie
authors: D
authors: D
authors: Droz
authors: R
authors: R
authors: Bouvier
authors: D
authors: D
authors: Chauveau
authors: D
authors: D
authors: Joly
authors: J P
authors: JP
authors: Grunfeld
authors: Y
authors: Y
authors: Chretien
authors: A
authors: A
authors: Mejean
authors: C
authors: C
authors: Beroud
mesh_terms: D000107:Acetylation; D001191:Arylamine N-Acetyltransferase / Q000235:genetics / Q000502:physiology; D001711:Biotransformation / Q000235:genetics; D002274:Carcinogens, Environmental / Q000009:adverse effects / Q000493:pharmacokinetics; D002292:Carcinoma, Renal Cell / Q000139:chemically induced / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control*; D019363:Cytochrome P-450 CYP1A1 / Q000235:genetics / Q000502:physiology; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics / Q000502:physiology; D004252:DNA Mutational Analysis; D004273:DNA, Neoplasm / Q000235:genetics; D004781:Environmental Exposure; D004785:Environmental Pollutants / Q000009:adverse effects / Q000493:pharmacokinetics; D004843:Epistasis, Genetic; D005502:Food / Q000009:adverse effects; D005506:Food Contamination; D005511:Food Handling; D005638:Fruit; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005838:Genotype; D005982:Glutathione Transferase / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D006801:Humans; D007527:Isoenzymes / Q000235:genetics / Q000502:physiology; D007680:Kidney Neoplasms / Q000139:chemically induced / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control*; D008025:Ligases; D008460:Meat / Q000009:adverse effects; D009747:Nutritional Physiological Phenomena; D009857:Oncogenes; D009928:Organ Specificity; D011506:Proteins / Q000235:genetics / Q000502:physiology*; D012307:Risk Factors; D017384:Sequence Deletion; D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases; D014675:Vegetables; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D015262:Xenobiotics / Q000493:pharmacokinetics; D006623:von Hippel-Lindau Disease / Q000453:epidemiology / Q000235:genetics*
chemical_list: D001191:Arylamine N-Acetyltransferase; D002274:Carcinogens, Environmental; D019363:Cytochrome P-450 CYP1A1; D003577:Cytochrome P-450 Enzyme System; D004273:DNA, Neoplasm; D004785:Environmental Pollutants; D005982:Glutathione Transferase; D007527:Isoenzymes; D008025:Ligases; D011506:Proteins; D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D015262:Xenobiotics; C089384:N-acetyltransferase 1; C478900:NAT2 protein, human; C497446:VHL protein, human